Alerts will be sent to your verified email
Verify Email
KSLIND
|
KSL & Industries
|
Skybiotech Healthcar
|
Spenta Intl.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
16.99 % | 3.54 % | 4.1 % |
|
5yr average Equity Multiplier
|
-0.95 | 1.38 | 2.08 |
|
5yr Average Asset Turnover Ratio
|
0.12 | 0.09 | 0.74 |
|
5yr Avg Net Profit Margin
|
-13284.23 % | -8.4 % | 0.99 % |
|
Price to Book
|
0.0 | 3.1 | 0.94 |
|
P/E
|
0.0 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
120.27 Days | 41.6 Days | 171.35 Days |
|
Inventory Days
|
55.39 Days | 20.62 Days | 121.92 Days |
|
Days Receivable
|
0.0 | 21.98 Days | 84.61 Days |
|
Days Payable
|
25.31 Days | 15.71 Days | 52.63 Days |
|
5yr Average Interest Coverage Ratio
|
-0.37 | -50.28 | 1.57 |
|
5yr Avg ROCE
|
-25.76 % | 0.32 % | 8.43 % |
|
5yr Avg Operating Profit Margin
|
-1974.42 % | -7.99 % | 6.58 % |
|
5 yr average Debt to Equity
|
-1.61 | 0.2 | 0.78 |
|
5yr CAGR Net Profit
|
-15.08 % | 126.22 % | n/a |
|
5yr Average Return on Assets
|
-17.81 % | -0.02 % | 1.35 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
39.22 % | 63.48 % | 64.71 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 5.69 % | 0.23 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
KSL & Industries
|
Skybiotech Healthcar
|
Spenta Intl.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|